02.06.2013 Views

Drug Eruption and Interactions - PHARMACEUTICAL REVIEW

Drug Eruption and Interactions - PHARMACEUTICAL REVIEW

Drug Eruption and Interactions - PHARMACEUTICAL REVIEW

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

(1998): Leal G, Fortaleza, Brazil (from Internet) (observation)<br />

(1992): Breathnach SM+, Adverse <strong>Drug</strong> Reactions <strong>and</strong> the Skin<br />

Blackwell, Oxford, 289<br />

(1992): Zonzits E+, Arch Dermatol 128, 80<br />

(1988): Pratt CB+, <strong>Drug</strong> Intell Clin Pharm 22, 913<br />

Mucosal<br />

Oral lesions<br />

(1988): Pralt CB+, <strong>Drug</strong> Intell Clin Pharm 22, 913<br />

Oral ulceration<br />

(1992): Breathnach SM+, Adverse <strong>Drug</strong> Reactions <strong>and</strong> the Skin<br />

Blackwell, Oxford, 289<br />

MESORIDAZINE<br />

Trade names: Mesorin; Serentil (Boehringer Ingelheim)<br />

Indications: Schizophrenia<br />

Category: Antipsychotic, phenothiazine<br />

Half-life: 24–48 hours<br />

Clinically important, potentially hazardous interactions<br />

with: antihistamines, arsenic, chlorpheniramine, dofetilide,<br />

lithium, piperazine, quinolones, sparfloxacin<br />

Reactions<br />

Skin<br />

Angioedema<br />

Dermatitis<br />

Eczema<br />

Edema<br />

Erythema<br />

Exfoliative dermatitis<br />

Lupus erythematosus<br />

Peripheral edema<br />

Photosensitivity (1–10%)<br />

Pigmentation (blue-gray) (

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!